Atopic dermatitis: an update.
This review focuses on recent literature regarding the following clinical features of atopic dermatitis (AD); diagnostic criteria, epidemiology and genetics, provocative factors, predictors of disease development and markers of disease severity, therapy, and prognosis. For example, the frequency of AD appears to be increasing, perhaps in response to provocative factors such as food allergens and house dust mites. Determination of reliable markers for disease development may identify susceptible newborns and facilitate avoidance of relevant triggers. Immunomodulating therapy holds promise in the treatment of refractory AD, and new investigation has led to refinements in conventional modalities such as antihistamines and phototherapy.
Rothe
M J
MJ
Department of Medicine, University of Connecticut Health Center, Farmington 06030, USA.
Grant-Kels
J M
JM
D000328:Adult; D000485:Allergens / Q000009:adverse effects; D002648:Child; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D004198:Disease Susceptibility; D005512:Food Hypersensitivity / Q000150:complications; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007231:Infant, Newborn; D010789:Phototherapy; D011379:Prognosis
D000485:Allergens; D006634:Histamine H1 Antagonists